Haisco Pharmaceutical Group Co., Ltd. at its 2nd Extraordinary General Meeting of 2023 on 25 August 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable: Wang Junmin, Fan Xiulian, Zheng Wei, Yan Pangke. Election and nomination of independent directors, cumulative voting system applicable: Yue Lin and Cao Chuande. Election of shareholder supervisors, cumulative voting system applicable: Liang Yuan and Sun Tao.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.64 CNY | -0.13% | +2.61% | +32.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.35% | 4.67B | |
+40.73% | 739B | |
+31.56% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.53% | 240B | |
+9.58% | 210B | |
-5.32% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 002653 Stock
- News Haisco Pharmaceutical Group Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes